Back to news

Tandem Diabetes Care Names Jeannette Bankes as President and Chief Executive Officer

Business Wire•05/11/2026•16:08 ET
0

Key Highlights

  • ➤Jeannette Bankes becomes Tandem CEO and board member effective November 16, 2026
  • ➤John Sheridan retires as CEO at 2026-end after more than a decade at Tandem
  • ➤Tandem grants Bankes inducement RSUs valued up to $10 million
  • ➤Bankes most recently led GE HealthCare’s $3.1 billion Patient Care Solutions segment
  • ➤Tandem technology benefits half a million people worldwide, Sheridan says

Expert Statements

Beckie Robertson, Chair of Tandem’s Board of Directors

“On behalf of the Board, I thank John for his significant contributions and dedication to our customers, employees and shareholders. He established Tandem as a global leader in diabetes technology and positioned the Company for its next phase of growth”

Beckie Robertson, Chair of Tandem’s Board of Directors

“Jeannette is the right CEO to build on this foundation. Her broad operating experience, focus on the people we serve and ability to translate innovation into impact will be critical as we seek to deliver new technology and drive profitable growth.”

John Sheridan, President and CEO of Tandem Diabetes Care

“It has been a privilege to serve as Tandem’s CEO and work alongside a dedicated organization united by our mission to improve the lives of people with diabetes, including half a million people worldwide who benefit from Tandem's technology”

John Sheridan, President and CEO of Tandem Diabetes Care

“Jeannette is an exceptional leader, and I am confident that she and the Tandem team have the capability, passion and commitment to guide the Company into its next chapter.”

Jeannette Bankes, Incoming President and CEO of Tandem Diabetes Care

“Tandem’s compelling mission, differentiated portfolio and global reach create a meaningful opportunity to improve the lives of more people with diabetes”

Jeannette Bankes, Incoming President and CEO of Tandem Diabetes Care

“I am excited to work alongside the talented people at Tandem to build on these strengths, advance the innovation pipeline and expand access to our technology. Through disciplined execution and a continued focus on customers, we can extend Tandem’s impact and deliver lasting value for the diabetes community and shareholders.”

Tandem Diabetes Care Names Jeannette Bankes as President and Chief Executive Officer

Planned Leadership Transition as John Sheridan Retires Following More Than a Decade of Service

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in